Oric PharmaceuticalsORIC
那斯達克 · USD
9.94
+0.11
(+1.12%)
收盤 08/15 03:59 (UTC+8)
08/15 03:59 (UTC+8)
Oric PharmaceuticalsORIC
9.94
+0.11
(+1.12%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 32,718 | - | - | - | 28,990 | 31,428 | 28,682 | 24,992 | 25,678 | 22,119 |
研發費用 | 24,640 | 31,970 | 31,202 | 28,940 | 21,960 | 24,481 | 22,388 | 18,787 | 19,516 | 16,295 |
推銷及管理費用 | 8,078 | 7,600 | 7,116 | 7,077 | 7,030 | 6,947 | 6,294 | 6,205 | 6,162 | 5,824 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -32,718 | -39,570 | -38,318 | -36,017 | -28,990 | -31,428 | -28,682 | -24,992 | -25,678 | -22,119 |
其他收入及費用 | 2,697 | 3,263 | 3,752 | 4,054 | 3,979 | 3,098 | 3,204 | 2,048 | 1,733 | 1,272 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -30,021 | -36,307 | -34,566 | -31,963 | -25,011 | -28,330 | -25,478 | -22,944 | -23,945 | -20,847 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -30,021 | -36,307 | -34,566 | -31,963 | -25,011 | -28,330 | -25,478 | -22,944 | -23,945 | -20,847 |
基本每股稅後盈餘(元) | -0.42 | -0.51 | -0.49 | -0.45 | -0.37 | - | -0.44 | -0.50 | -0.53 | -0.52 |
稀釋每股稅後盈餘(元) | -0.42 | -0.51 | -0.49 | -0.46 | -0.37 | -0.50 | -0.43 | -0.50 | -0.53 | -0.52 |
基本平均股數(千股) | 71040.00 | 70652.00 | 70542.00 | 70348.00 | 67349.00 | - | 57402.00 | 45654.00 | 45090.00 | 40125.00 |
稀釋平均股數(千股) | 71040.00 | 70652.00 | 70542.00 | 70348.00 | 67349.00 | - | 57402.00 | 45654.00 | 45090.00 | 40125.00 |
還原基本每股稅後盈餘(元) | -0.42 | -0.51 | -0.49 | -0.45 | -0.37 | - | -0.44 | -0.50 | -0.53 | -0.52 |
還原稀釋每股稅後盈餘(元) | -0.42 | -0.51 | -0.49 | -0.46 | -0.37 | -0.50 | -0.43 | -0.50 | -0.53 | -0.52 |
還原基本平均股數(千股) | 71,040 | 70,652 | 70,542 | 70,348 | 67,349 | - | 57,402 | 45,654 | 45,090 | 40,125 |
還原稀釋平均股數(千股) | 71,040 | 70,652 | 70,542 | 70,348 | 67,349 | - | 57,402 | 45,654 | 45,090 | 40,125 |
EBITDA(千元) | -30,601 | -37,637 | -36,242 | -33,987 | -26,977 | -30,190 | -27,143 | -23,948 | -24,553 | -21,220 |